• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 3. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170

3-Bromo-N-pentylbenzenesulfonamide (CAS No. 1072944-95-6): An Overview of a Versatile Compound in Medicinal Chemistry

3-Bromo-N-pentylbenzenesulfonamide (CAS No. 1072944-95-6) is a compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural properties and potential therapeutic applications. This article aims to provide a comprehensive overview of 3-Bromo-N-pentylbenzenesulfonamide, including its chemical structure, synthesis methods, biological activities, and recent research advancements.

Chemical Structure and Properties

3-Bromo-N-pentylbenzenesulfonamide is a brominated benzenesulfonamide derivative. Its molecular formula is C₁₁H₁₅BrNO₂S, and it has a molecular weight of 305.21 g/mol. The compound features a benzene ring substituted with a bromine atom at the 3-position and an N-pentylsulfonamide group. The presence of the bromine atom and the sulfonamide functional group imparts unique chemical properties to this molecule, making it an interesting candidate for various applications in medicinal chemistry.

Synthesis Methods

The synthesis of 3-Bromo-N-pentylbenzenesulfonamide can be achieved through several routes, each with its own advantages and limitations. One common method involves the reaction of 3-bromobenzenesulfonyl chloride with pentylamine in the presence of a base such as triethylamine. This reaction typically proceeds via nucleophilic substitution, resulting in the formation of the desired product. Another approach involves the sulfonation of 3-bromobenzene followed by reaction with pentylamine. Both methods have been reported in the literature and are widely used in laboratory settings.

Biological Activities

3-Bromo-N-pentylbenzenesulfonamide has been studied for its potential biological activities, particularly in the context of drug discovery and development. Recent research has shown that this compound exhibits promising anti-inflammatory properties. In vitro studies have demonstrated that it can inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6 in human macrophages. These findings suggest that 3-Bromo-N-pentylbenzenesulfonamide may have therapeutic potential in treating inflammatory diseases.

In addition to its anti-inflammatory effects, 3-Bromo-N-pentylbenzenesulfonamide has also been investigated for its antiproliferative activity against cancer cells. Studies have shown that it can induce apoptosis in various cancer cell lines, including breast cancer and colon cancer cells. The mechanism of action appears to involve the modulation of signaling pathways associated with cell proliferation and survival.

Clinical Applications and Research Advancements

The potential clinical applications of 3-Bromo-N-pentylbenzenesulfonamide are currently being explored through preclinical studies and early-stage clinical trials. One area of focus is its use as an adjunct therapy for inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. Preclinical studies have shown promising results, with the compound demonstrating significant efficacy in reducing inflammation and improving disease outcomes.

In the context of cancer therapy, 3-Bromo-N-pentylbenzenesulfonamide is being evaluated for its ability to enhance the effectiveness of existing treatments. Combination therapies involving this compound have shown synergistic effects in preclinical models, suggesting that it may be a valuable addition to current treatment regimens.

Safety and Toxicology

The safety profile of 3-Bromo-N-pentylbenzenesulfonamide is an important consideration for its potential therapeutic use. Preclinical toxicology studies have indicated that this compound is generally well-tolerated at therapeutic doses, with no significant adverse effects observed in animal models. However, further studies are needed to fully characterize its safety profile in humans.

FUTURE DIRECTIONS AND CONCLUSIONS

The ongoing research on 3-Bromo-N-pentylbenzenesulfonamide highlights its potential as a valuable tool in medicinal chemistry. Its unique chemical structure and diverse biological activities make it an attractive candidate for further investigation. Future studies should focus on optimizing its pharmacological properties, exploring new therapeutic applications, and conducting more extensive safety evaluations.

In conclusion, 3-Bromo-N-pentylbenzenesulfonamide (CAS No. 1072944-95-6) is a promising compound with significant potential in various areas of medicinal chemistry. Its anti-inflammatory and antiproliferative properties make it a valuable target for drug discovery and development efforts. As research continues to advance, it is likely that this compound will play an increasingly important role in addressing unmet medical needs.

• 61714-23-6(1-Naphthalenesulfonamide, N-(5-aminopentyl)-5-bromo-, hydrochloride (1:1))
• 61714-30-5(1-Naphthalenesulfonamide, N-(8-aminooctyl)-5-bromo-, hydrochloride (1:1))
• 61714-26-9(1-Naphthalenesulfonamide, N-(6-aminohexyl)-5-bromo-, hydrochloride (1:1))
• 876694-43-8(3-Bromo-N-cyclopropylbenzenesulfonamide)
• 85353-17-9(2-Naphthalenesulfonamide, N-(6-aminohexyl)-5-bromo-)
• 1984-28-7(N-Butyl 4-bromobenzenesulfonamide)
• 1837-70-3(Benzenesulfonamide,4-bromo-N-hexadecyl-)
• 61714-29-2(1-Naphthalenesulfonamide, N-(7-aminoheptyl)-5-bromo-,monohydrochloride)
• 871269-09-9(N-Butyl 3-bromobenzenesulfonamide)
• 7454-76-4(N-Cyclohexyl 4-bromobenzenesulfonamide)